Developer docs
API playgroundTry for free, no card

Search company profiles

Unilabs

Full company profile

uuid003l61r

Namestring
Unilabs
Legal namestring
Unilabs AB
Company typeenum
Private
Founded yearint
1987
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersGeneva, Switzerland
HQ citystring
Geneva
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory testing, diagnostic imaging services, pathology diagnostics, genetic testing services, teleradiology services
Industry2 codes
1Reference & Esoteric Testing Laboratories
CodeHLAFAMAJPrimaryYes
2Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
CodeHLAGAEABPrimaryNo
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • Ambulatory Health Care Services621
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Health Services8000
Product category
Clinical Diagnostic Services
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model6 records
1Clinical Laboratory Testing Services
TypeSubscription Recurring
Description

Provides accurate, timely and clinically meaningful laboratory diagnostic information supporting diagnosis, treatment and monitoring. Delivers hundreds of millions of tests annually with standardised processes and strong quality controls.

unilabs.com
2Radiology and Imaging Services
TypeSubscription Recurring
Description

Complete diagnostic imaging service across every modality including X-ray, CT, MRI, Ultrasound, Mammography, DEXA, OPG, and specialty scans. Supported by subspecialty radiologists and fast, structured reporting.

unilabs.com
3Pathology Services
TypeSubscription Recurring
Description

Histopathology and cytology services including molecular pathology. Complete digital pathology workflows and AI-enabled analysis. More than 18 specialities covered.

unilabs.com
4Genetics Services
TypeSubscription Recurring
Description

Portfolio of more than 4,000 customisable genetic tests covering reproductive health, neurodevelopment, rare diseases, oncology, genetic risk assessment, and clinical trials.

unilabs.com
5Healthcare System Partnerships
TypeManaged Services
Description

Long-term partnerships with hospitals, healthcare institutions and healthcare systems to provide diagnostic services at scale, supporting efficient operations and informed clinical decision-making.

unilabs.com
6Pharma and Contract Research Partnerships
TypeProfessional Services
Description

Support for pharma, CROs, biotech, medtech and industry partners across the research and development journey, from early studies to large multi-site trials.

unilabs.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details2 tiers
1Enterprise healthcare partnerships
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Volume-based diagnostic service agreements with hospitals, healthcare systems and institutions. Pricing customized based on test volume, modality mix, and service scope.

unilabs.com
2Individual patient services
ModelOtherBilling cadencePay-as-you-go
Notes

Direct patient services accessible through patient centres across Europe. Specific pricing not publicly disclosed as it varies by market and service type.

unilabs.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 3 records shown
1Telemedicine Clinic (TMC)
Description

Teleradiology services providing daily services to more than 150 European hospitals with over 350 subspecialist radiologists

unilabs.com
+2 more records
Core offering1 text field

Unilabs provides full-spectrum diagnostic services across four modalities — Clinical Laboratory Testing, Radiology, Pathology, and Genetics — delivered through a pan-European network of laboratories, imaging centres, patient centres, and sample collection points. Services include routine and specialised laboratory testing, diagnostic imaging (X-ray, CT, MRI, ultrasound, mammography), histopathology and cytology, and genetic testing, with adjacent offerings in teleradiology, accredited radiology training, and pharma/CRO research support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 245+ million diagnostic tests performed annually including 237 million laboratory tests, 6 million imaging examinations, and 9 million pathology sections
+3 more records
Product overview1 text field

Unilabs is a full-spectrum diagnostics provider offering integrated diagnostic services across four core modalities: Clinical Laboratory Testing, Radiology, Pathology, and Genetics. The company operates as a unified platform combining local expertise with European scale across 12 countries. Supporting services include Unilabs Academy (accredited radiology training), Telemedicine Clinic/Teleradiology (network of 350+ radiologists), and Unilabs Pharma Solutions for pharmaceutical and research partnerships. The portfolio delivers over 245 million tests annually including laboratory tests, imaging examinations, and pathology analyses, supporting informed healthcare decisions across the patient care pathway from prevention and early detection to treatment guidance and monitoring.

Product and service1 record
1Clinical Laboratory Testing
Scale indicator19 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or Integration
Description

Telemedicine Clinic is a wholly-owned subsidiary providing teleradiology services with over 350 radiologists working together as a collaborative subspecialist network. TMC provides daily services to more than 150 European hospitals and radiology groups with both elective and emergency reporting services. Part of Unilabs' strategy to deliver advanced imaging technologies at scale.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

More than 150 European hospitals and radiology groups receive daily teleradiology services from TMC, including both elective and emergency reporting. These institutional partnerships form the core customer base for teleradiology services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Unilabs supports partners across the research and development journey, from early studies to large multi-site trials, with the quality and rigour their work demands. Collaboration helps turn discovery into diagnostics that reach patients.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Synlab is the largest pan-European medical diagnostics provider, offering clinical laboratory, radiology and specialty testing across 30+ countries. It is the most direct competitor to Unilabs' full-spectrum model, serving the same healthcare professionals, hospitals and pharma clients with overlapping four-modality coverage.

TypeRegional player
Description

Medicover is a healthcare and diagnostics provider primarily serving Central and Eastern Europe with clinics and laboratories. It overlaps with Unilabs in CEE diagnostics (where Unilabs runs Czech Republic, Slovakia, Hungary operations) and competes for the same regional hospital and patient segments.

TypeBroad incumbent
Description

Quest Diagnostics is the largest US clinical laboratory operator with growing international and advanced diagnostics franchises. It competes with Unilabs in advanced diagnostics and reference testing and is a comparable global incumbent.

TypeOthers
Description

BioMérieux is a leading in-vitro microbiology and clinical diagnostics manufacturer supplying reagents and platforms to European hospital labs. It is adjacent to Unilabs' microbiology and infectious disease testing rather than a direct competitor, but competes for the same test menu in hospital labs.

TypeDirect peer
Description

Eurofins operates a global network of laboratories providing clinical diagnostics and pharma testing services alongside its food/environment testing business. Its clinical diagnostics arm (Eurofins Genoma, LifeCodex, etc.) overlaps with Unilabs' genetics and specialty testing portfolio.

TypeBroad incumbent
Description

Labcorp is one of the world's largest clinical laboratory networks, with global central-lab/CRO capabilities via Labcorp Drug Development. It is a broader incumbent that competes with Unilabs in clinical trials, esoteric testing and routine diagnostics.

TypeBroad incumbent
Description

Sonic Healthcare is a global diagnostics provider operating clinical laboratories and radiology practices across the US, Europe, Australia and Germany. Its European operations (formerly Synlab) and German LADR network overlap directly with Unilabs' lab testing and radiology offerings.

TypeBroad incumbent
Description

Roche Diagnostics is the world's largest in-vitro diagnostics manufacturer, supplying assays, instruments and increasingly digital solutions to labs including Unilabs. While upstream of Unilabs' lab operations, its cobas and digital pathology offerings shape the competitive context for Unilabs' laboratory business.

TypeDirect peer
Description

Cerba Healthcare is a European specialty diagnostics and clinical-trial-laboratory group operating reference labs and central labs across Europe. It competes with Unilabs in reference/esoteric testing, pathology, genetics and CRO trial support, with comparable multi-country European footprint.

TypeRegional player
Description

Affidea operates outpatient diagnostic-imaging centres (MRI, CT, X-ray) and selected lab services across Europe, with the COO of Unilabs (Michal Kwiecinski) formerly heading Affidea Western Europe. It is comparable to Unilabs' radiology and imaging operations across European markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A9 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Unilabs

Clinical Diagnostic Servicesunilabs.com

Unilabs firmographics

Firmographics
Name
Unilabs
Legal name
Unilabs AB
Website
http://www.unilabs.com/
Company type
Private
Founded year
1987
Operating status
Operating
Headcount range
5,001–10,000 employees
Ownership category
akta.pro rank

Unilabs industry classification

Industry
Product category
Clinical Diagnostic Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Ambulatory Health Care Services (621)
SIC
Services-Medical Laboratories (8071), Services-Health Services (8000)
akta.pro primary industry
Reference & Esoteric Testing Laboratories (HLAFAMAJ)
akta.pro secondary industry
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

  • Clinical laboratory testing
  • Diagnostic imaging services
  • Pathology diagnostics
  • Genetic testing services
  • Teleradiology services

Where Unilabs is headquartered

Location

Headquarters

HQ city
Geneva
HQ country
Switzerland
HQ region
Europe

Offices10 records

Markets served

Unilabs business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Clinical Laboratory Testing Services: Provides accurate, timely and clinically meaningful laboratory diagnostic information supporting diagnosis, treatment and monitoring. Delivers hundreds of millions of tests annually with standardised processes and strong quality controls.
  2. Radiology and Imaging Services: Complete diagnostic imaging service across every modality including X-ray, CT, MRI, Ultrasound, Mammography, DEXA, OPG, and specialty scans. Supported by subspecialty radiologists and fast, structured reporting.
  3. Pathology Services: Histopathology and cytology services including molecular pathology. Complete digital pathology workflows and AI-enabled analysis. More than 18 specialities covered.
  4. Genetics Services: Portfolio of more than 4,000 customisable genetic tests covering reproductive health, neurodevelopment, rare diseases, oncology, genetic risk assessment, and clinical trials.
  5. Healthcare System Partnerships: Long-term partnerships with hospitals, healthcare institutions and healthcare systems to provide diagnostic services at scale, supporting efficient operations and informed clinical decision-making.
  6. Pharma and Contract Research Partnerships: Support for pharma, CROs, biotech, medtech and industry partners across the research and development journey, from early studies to large multi-site trials.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise healthcare partnerships
OtherPay-as-you-goIndividual patient services

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Unilabs product offering

Product offering

Core offering

Unilabs provides full-spectrum diagnostic services across four modalities — Clinical Laboratory Testing, Radiology, Pathology, and Genetics — delivered through a pan-European network of laboratories, imaging centres, patient centres, and sample collection points. Services include routine and specialised laboratory testing, diagnostic imaging (X-ray, CT, MRI, ultrasound, mammography), histopathology and cytology, and genetic testing, with adjacent offerings in teleradiology, accredited radiology training, and pharma/CRO research support.

Product overview

Unilabs is a full-spectrum diagnostics provider offering integrated diagnostic services across four core modalities: Clinical Laboratory Testing, Radiology, Pathology, and Genetics. The company operates as a unified platform combining local expertise with European scale across 12 countries. Supporting services include Unilabs Academy (accredited radiology training), Telemedicine Clinic/Teleradiology (network of 350+ radiologists), and Unilabs Pharma Solutions for pharmaceutical and research partnerships. The portfolio delivers over 245 million tests annually including laboratory tests, imaging examinations, and pathology analyses, supporting informed healthcare decisions across the patient care pathway from prevention and early detection to treatment guidance and monitoring.

Differentiator

Problem solved

Functional benefit

Brands

  • Telemedicine Clinic (TMC): Teleradiology services providing daily services to more than 150 European hospitals with over 350 subspecialist radiologists
  • Unilabs Academy
  • Unilabs Pharma Solutions

Products and services

  • Clinical Laboratory Testing

Quantifiable outcome

  • 245+ million diagnostic tests performed annually including 237 million laboratory tests, 6 million imaging examinations, and 9 million pathology sections
  • +3 more outcomes

Companies that use Unilabs

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Unilabs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature9 records

Unilabs partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Telemedicine Clinic (TMC)coreTechnology or IntegrationTelemedicine Clinic is a wholly-owned subsidiary providing teleradiology services with over 350 radiologists working together as a collaborative subspecialist network. TMC provides daily services to more than 150 European hospitals and radiology groups with both elective and emergency reporting services. Part of Unilabs' strategy to deliver advanced imaging technologies at scale.
  • European hospitals and radiology groups (150+)coreChannel Partner/ Reseller/ DistributorMore than 150 European hospitals and radiology groups receive daily teleradiology services from TMC, including both elective and emergency reporting. These institutional partnerships form the core customer base for teleradiology services.
  • Pharma, CROs, Biotech and Medtech PartnerscoreStrategic or Co-development PartnerUnilabs supports partners across the research and development journey, from early studies to large multi-site trials, with the quality and rigour their work demands. Collaboration helps turn discovery into diagnostics that reach patients.

Scale indicators19 records

Recent moves6 records

Expansion highlights6 records

Unilabs competitors and assessment

Company assessment

Direct peers

  • Synlab: Synlab is the largest pan-European medical diagnostics provider, offering clinical laboratory, radiology and specialty testing across 30+ countries. It is the most direct competitor to Unilabs' full-spectrum model, serving the same healthcare professionals, hospitals and pharma clients with overlapping four-modality coverage.
  • Eurofins Scientific: Eurofins operates a global network of laboratories providing clinical diagnostics and pharma testing services alongside its food/environment testing business. Its clinical diagnostics arm (Eurofins Genoma, LifeCodex, etc.) overlaps with Unilabs' genetics and specialty testing portfolio.
  • Cerba Healthcare: Cerba Healthcare is a European specialty diagnostics and clinical-trial-laboratory group operating reference labs and central labs across Europe. It competes with Unilabs in reference/esoteric testing, pathology, genetics and CRO trial support, with comparable multi-country European footprint.

Regional players

  • Medicover: Medicover is a healthcare and diagnostics provider primarily serving Central and Eastern Europe with clinics and laboratories. It overlaps with Unilabs in CEE diagnostics (where Unilabs runs Czech Republic, Slovakia, Hungary operations) and competes for the same regional hospital and patient segments.
  • Affidea: Affidea operates outpatient diagnostic-imaging centres (MRI, CT, X-ray) and selected lab services across Europe, with the COO of Unilabs (Michal Kwiecinski) formerly heading Affidea Western Europe. It is comparable to Unilabs' radiology and imaging operations across European markets.

Broad incumbents

  • Quest Diagnostics: Quest Diagnostics is the largest US clinical laboratory operator with growing international and advanced diagnostics franchises. It competes with Unilabs in advanced diagnostics and reference testing and is a comparable global incumbent.
  • Labcorp (Laboratory Corporation of America): Labcorp is one of the world's largest clinical laboratory networks, with global central-lab/CRO capabilities via Labcorp Drug Development. It is a broader incumbent that competes with Unilabs in clinical trials, esoteric testing and routine diagnostics.
  • Sonic Healthcare: Sonic Healthcare is a global diagnostics provider operating clinical laboratories and radiology practices across the US, Europe, Australia and Germany. Its European operations (formerly Synlab) and German LADR network overlap directly with Unilabs' lab testing and radiology offerings.
  • Roche Diagnostics: Roche Diagnostics is the world's largest in-vitro diagnostics manufacturer, supplying assays, instruments and increasingly digital solutions to labs including Unilabs. While upstream of Unilabs' lab operations, its cobas and digital pathology offerings shape the competitive context for Unilabs' laboratory business.

Others

  • BioMérieux: BioMérieux is a leading in-vitro microbiology and clinical diagnostics manufacturer supplying reagents and platforms to European hospital labs. It is adjacent to Unilabs' microbiology and infectious disease testing rather than a direct competitor, but competes for the same test menu in hospital labs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks7 records

Key highlights7 records

Customer concentration

Unilabs social profiles

Digital presence

Unilabs compliance and trust

Trust signal

Compliance9 records

Unilabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Unilabs leadership team

Management profile

Number of profiles

Profiles11 records

Unilabs subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Unilabs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Unilabs M&A and investment

M&A and investment

M&A9 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Unilabs

What does Unilabs do?

Unilabs provides full-spectrum diagnostic services across four modalities — Clinical Laboratory Testing, Radiology, Pathology, and Genetics — delivered through a pan-European network of laboratories, imaging centres, patient centres, and sample collection points. Services include routine and specialised laboratory testing, diagnostic imaging (X-ray, CT, MRI, ultrasound, mammography), histopathology and cytology, and genetic testing, with adjacent offerings in teleradiology, accredited radiology training, and pharma/CRO research support.

Is Unilabs a public or private company?

Unilabs is a private company. It is classified as unknown and is currently operating.

When was Unilabs founded?

Unilabs was founded in 1987. It employs 5,001 to 10,000 people.

Where is Unilabs based?

Unilabs is headquartered in Geneva, Switzerland, in the Europe region.

How does Unilabs make money?

Six revenue lines are on record. Clinical Laboratory Testing Services are the primary driver. The others are radiology and Imaging Services, pathology Services, genetics Services, healthcare System Partnerships and pharma and Contract Research Partnerships.

Who are Unilabs's main competitors?

Direct peers on record are Synlab, Eurofins Scientific and Cerba Healthcare. Regional players are Medicover and Affidea. Broad incumbents are Quest Diagnostics, Labcorp (Laboratory Corporation of America), Sonic Healthcare and Roche Diagnostics. BioMérieux is listed as an others.

Does Unilabs have an API?

No public API is recorded for Unilabs.

What industry is Unilabs in?

Unilabs's product category is Clinical Diagnostic Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories, with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EntarabiHub71 and Unilabs Join Forces.. UAE Partnership Opens New Markets for HealthTech StartupsHub71 and Unilabs partnered to connect Abu Dhabi HealthTech startups with diagnostics and clinical expertise. The collaboration includes Takalam's mental-health platform and GlycanAge's biological-age testing, aiming to move startups from development to commercial adoption. The initiative reflects Abu Dhabi's shift toward integrated health innovation ecosystems.The HindubioAsia 2026: Hyderabad’s rise as AI innovation hub for global healthcare companies highlightedExecutives from multinational pharmaceutical and medical technology companies gathered at BioAsia 2026 in Hyderabad on February 18, 2026, to discuss how the city is emerging as a key hub for building AI-driven capabilities through Global Capability Centres (GCCs). Several firms, including Novartis, Takeda, Amgen, Olympus Corporation, and Unilabs, highlighted that their India-based GCCs have evolved from cost-focused centres to high-impact innovation engines, with Takeda designating India as its flagship innovation location within its global network.Business Wire BlogWHOOP Launches Advanced Labs in the UAE with Diagnostic Partner Unilabs, Delivering A Comprehensive View of Health For MembersWHOOP has partnered with Unilabs, an international medical diagnostic services provider, to launch its WHOOP Advanced Labs offering in the UAE, allowing members to book a 65-biomarker blood panel at Unilabs centers. The lab results can be uploaded to the WHOOP app and combined with continuous biometric data such as recovery, sleep, and strain to provide members with a comprehensive view of their health. The partners plan to expand the collaboration further with deeper data integration over time, with pricing set at 733 AED for the panel.WHOOPPress CenterWHOOP, a human performance company, announced a partnership with Unilabs, an international medical diagnostic services provider, to expand WHOOP Advanced Labs in the UAE. The collaboration enables WHOOP members to book a 65-biomarker panel through Unilabs centers across the UAE or via home collection, with results uploaded directly to the WHOOP app for integration with continuous biometric data. The companies plan to deepen data integration over time, with pricing set at 733 AED for the panel.The Times of IndiaGlobal scientific leaders, AI pioneers to converge at BioAsia 2026The 23rd edition of BioAsia 2026, Asia's leading life sciences and healthcare conference, will be held in Hyderabad, India on February 17–18, 2026, under the theme "TechBio Unleashed: AI, Automation & the Biology Revolution", focusing on how AI, advanced biology, and intelligent manufacturing are converging to reshape therapy discovery, development, and delivery worldwide. The conference will feature executives and leaders from major pharmaceutical and biotech companies including Sanofi, Google DeepMind, Amgen, Miltenyi Biotec, MSD, Novartis, Medtronic, Eli Lilly, and Unilabs, alongside sessions on Telangana's roadmap to position Hyderabad among the top five global life sciences hubs. The event follows the Telangana government's unveiling of its new life sciences policy 2026–30 at the World Economic Forum in Davos and aligns with the state's "Telangana Rising Vision 2047" for innovation-led growth.TRIPURA STAR NEWSBioasia 2026 To Convene The World’s Leading Science, AI, And Industry Pioneers Driving The Techbio Revolution.BioAsia 2026, an international life sciences and healthcare forum, will convene global leaders in science, AI, and industry in Hyderabad on February 17-18, 2026, to discuss innovations in healthcare technology. The conference will focus on AI, biology, and manufacturing converging to transform healthcare discovery, development, and delivery, with Telangana reaffirming its commitment to becoming a top life sciences hub. Key speakers will include executives from Miltenyi Biotec, Amgen, Google DeepMind, Sanofi, MSD, Novartis, Medtronic, Eli Lilly, and Unilabs.MoinMultilingual Chatbots: Applications, Benefits & Practical ExamplesThe article outlines the applications and benefits of multilingual AI chatbots for international customer service, highlighting use cases in e-commerce, healthcare, and publishing. It cites specific implementations by Teleboy and Unilabs using moinAI technology to automate inquiries and improve support efficiency. The text also discusses selection criteria for chatbot providers, such as generative AI capabilities and integration features.FinancialContent Business PageFlow Cytometry Services Market Report 2025, with Profiles of FlowMetric, Flow Contract Sites Laboratory, Bio-Legend, Q2 Solutions, ProImmune, MLM Medical Labs, Unilabs, Firalis, and Agilex BiolabsResearchAndMarkets.com added a market research report on the global flow cytometry services market to its offerings, valuing the market at USD 2.76 billion in 2025 and projecting a compound annual growth rate of 9.73% through 2035. The report identifies approximately 30 companies offering flow cytometry services, with the majority based in North America and over 70% providing analysis-based flow cytometric services. Key players profiled include FlowMetric Life Sciences, Q2 Solutions, Bio-Legend, ProImmune, MLM Medical Labs, Unilabs, Firalis, and Agilex Biolabs, with the report noting that market consolidation activity has increased in recent years through mergers and acquisitions.C2nC2N Diagnostics and Unilabs Announce Global Partnership, Bringing Together Innovation Leaders in Diagnostics and Laboratory Medicine to Advance Brain Health — C2N DiagnosticsC2N Diagnostics and Unilabs signed a multi-year partnership to expand access to C2N's Precivity blood tests for Alzheimer's disease in Europe, Norway, Switzerland, the UK, Peru, Saudi Arabia, and the UAE. The agreement includes a technology transfer to build a Unilabs testing network across Europe, with tests expected available to customers over coming months.MedTech DiveUnilabs inks deal to sell C2N Alzheimer’s blood tests in EuropeUnilabs agreed to exclusively distribute C2N Diagnostics' Alzheimer's blood tests in Europe, Peru, Saudi Arabia, and the UAE. The tests detect amyloid plaques and tau tangles, with a CE mark in 2020. Unilabs expects to make them available to customers in coming months.